MKTX vs VRDN · P/E 13, rev $451.8M vs rev $425.0K
MarketAxess Holdings Inc (MKTX) versus Viridian Therapeutics Inc (VRDN) — a side-by-side from cached financials, not a winner call.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
Latest reported MKTX revenue for 2026-06-30 was $451.8M. Net income was $146.0M. Revenue was up 93.6% from 2026-03-31 to 2026-06-30. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Latest reported VRDN revenue for 2026-06-30 was $425.0K. Net income was -$232.0M. VRDN currently screens at market cap $1.39B.
MKTX currently screens at market cap $4.00B and trailing P/E 13.3. VRDN currently screens at market cap $1.39B.
Not investment advice. Open the MKTX and VRDN stock pages for the full models.
Not investment advice.